Have you been tempted to translate online?
October 14, 2014The need to communicate across the world is growing every day and with it the demand for translation services, particularly …
BMS, Pharmacyclics and Janssen collaborate on cancer
October 14, 2014Research and Development, Sales and Marketing BMS, Janssen, Pharmacyclics, imbruvica, opdivo
Bristol-Myers Squibb, Pharmacyclics and Janssen are to collaborate on clinical trials combining BMS’s cancer drug Opdivo (nivolumab) with Janssen and …
Chinese military-linked firm says it has Ebola cure
October 14, 2014Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp
A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …
NICE releases ‘person-centred’ medicines optimisation guidelines
October 14, 2014Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead
NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …
Pfizer breast cancer pill gets FDA nod
October 14, 2014Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …
Havas Life Medicom recruits from Pan
October 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jon Linscott, Pan, havas life medicom
Healthcare comms firm Havas Life Medicom has appointed Jon Linscott to its team to serve as a senior director. Linscott …
Hospira recalls drug due to storage hiccup
October 13, 2014Manufacturing and Production, Sales and Marketing FDA, Hospira, Vancocin, Vancomycin hydrochloride, lilly
Hospira has issued a recall of one lot of its injectable vancomycin hydrochloride in the US due to ‘uncontrolled storage …
Steris to buy UK’s Synergy Health for $1.9 billion
October 13, 2014Manufacturing and Production, Sales and Marketing health, manufacturing, steris, synergy, tax
US-based medical technology firm Steris Corporation is to purchase Synergy Health in the UK for $1.9 billion and will shift …
EMA keeps Ariad cancer drug on the market
October 13, 2014Sales and Marketing Ariad, CML, EMA, PRAC, iclusig, leukaemia, ponatinib
The EMA has recommended Ariad’s leukaemia drug Iclusig (ponatinib) should continue to be used under its current indication despite ongoing …
NHS staff striking over pay
October 13, 2014Medical Communications, Sales and Marketing British Association of Occupational Therapists., GMB, GPs, Hunt, NHS, UCATT, midwives, strike
Over 400,000 NHS staff have gone on strike for four hours as a 1% pay rise requested by Unions was …
Patricell appoints sales executive
October 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carla stemate, patricell
Nottingham-based healthcare products firm Patricell is adding Carla Stemate to its team as a sales executive. Based at BioCity, Stemate …
Pharma and transparency: actions speak louder than words
October 13, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, alltrials, andrew powrie-smith, hcp, transparency
As an industry we continue to deliver innovative, life changing medicines and rewrite the story of many diseases, yet our …
Novartis signs $90m deal with Oxford BioMedica
October 10, 2014Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb
UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …
Endo buys Auxilium for $2.6 billion
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo, Testim, Testopel, auxilum
Endo International has agreed a $2.6 billion deal to buy Auxilium Pharmaceuticals in order for the company to gain access …
New chief executive for Tonic Life Communications
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntsworth Health, mary smiddy, tonic life communications
Healthcare comms consultancy Tonic Life Communications that is a part of the Huntsworth Health family of agencies, has confirmed the …
AstraZeneca president to lead Sanofi UK
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Sanofi, Tarja Stenvall
Sanofi has appointed Tarja Stenvall to be its new general manager for the UK and Ireland. Stenvall joins Sanofi from …
Charity launches second cancer research game
October 9, 2014Medical Communications, Sales and Marketing CRUK, Cancer, amazon, genes in space, oncology, play, reverse the odds
Cancer Research UK has launched its second citizen science game this year called ‘Reverse The Odds’ in an attempt to …
Supervisory board member joins Bayer
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Otmar Wiestler
Professor Otmar Wiestler has been appointed to the supervisory board at German pharma giant Bayer. He replaces Dr Klaus Kleinfeld …
Texas Ebola victim dies as diseases spreads
October 9, 2014Medical Communications, Sales and Marketing Chicago O’Hare, Ebola, Hartsfield-Jackson Atlanta, Newark Liberty, Thomas Eric Duncan, UK, US, Washington Dulles
A Liberian national named Thomas Eric Duncan has died in an isolation ward of a Dallas, Texas hospital after being …
Novartis says three executives departing firm
October 9, 2014Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines
Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
